Cadrenal Therapeutics CVKD Cash Flow Statement (2022-2026)

NASDAQ CVKD
$1.09 -0.03 (-2.68%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Cadrenal Therapeutics Quarterly Cash Flow Statement

Periods 18 quarters
Latest Jun 2026

Cadrenal Therapeutics reported cash from operations of -$2.23M and free cash flow of -$2.23M for the quarter ended Jun 2026, up 26.2% year over year. This cash flow statement covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -0.17M-0.49M-0.99M-1.09M-4.20M-1.00M-1.04M-1.14M-1.66M-2.39M-2.41M-3.67M-3.32M
Depreciation and DepletionDep. & Depletion 506.00760.00190.00597.00597.00597.00597.00470.00407.00407.000.01M401.00401.00555.00555.00504.00
Share-based CompensationStock Comp. 0.45M0.29M0.17M0.15M0.10M0.16M0.19M0.30M0.76M0.55M0.59M0.47M0.33M0.25M0.67M
Cash from OperationsCash from Ops. -0.04M-0.45M-0.42M-0.29M-1.41M-0.80M-0.63M-0.69M-1.84M-1.53M-2.20M-1.79M-4.65M-3.03M-2.36M-2.57M-3.00M-2.23M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 506.00760.00190.00597.00597.00597.00597.00470.00407.00407.000.01M401.00401.00555.00555.00504.00
Change in Working Capital
Change in Account PayablesChange Payables 0.02M0.19M0.10M0.10M-0.29M-0.04M0.06M0.03M0.23M0.36M-0.26M1.01M-0.22M-0.38M-0.28M0.04M0.17M0.05M
Change in Accured ExpensesChange Accured Exp. 0.12M0.02M0.23M0.50M-0.60M0.01M0.12M0.24M-0.20M0.26M0.07M0.41M-0.62M0.22M-0.05M0.20M-0.70M0.33M
Other Working Capital ChangesOther WC Changes 0.00M0.03M-0.00M-0.00M0.28M-0.07M-0.07M-0.12M0.21M-0.05M-0.04M-0.14M0.53M-0.22M-0.24M0.08M0.23M-0.02M
Investing Activities
Capital ExpendituresCapex 1.001.000.00M0.00M
Cash from Investing ActivitiesCash from Investing -1.00-1.00-0.00M-0.00M
Financing Activities
Cash from Financing ActivitiesCash from Financing 0.51M0.05M0.46M0.22M5.41M6.51M-0.01M298.001.53M7.45M1.97M1.26M0.65M2.72M1.30M2.31M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued 0.01M450.005.41M298.001.64M3.51M2.06M1.29M0.67M0.85M1.37M1.20M
Additional items
Change in Cash 0.46M-0.40M0.04M-0.07M4.00M-0.80M5.88M-0.71M-1.84M-1.53M-0.67M5.65M-2.68M-1.77M-1.71M0.15M-1.70M0.08M
Free Cash FlowFCF -0.04M-0.45M-0.42M-0.29M-1.41M-0.80M-0.63M-0.69M-1.84M-1.53M-2.20M-1.79M-4.65M-3.03M-2.36M-2.57M-3.00M-2.23M
Net Cash FlowNCF 0.46M-0.40M0.05M-0.07M4.00M-0.80M5.88M-0.71M-1.84M-1.53M-0.67M5.66M-2.68M-1.77M-1.71M0.15M-1.70M0.08M

Cadrenal Therapeutics Cash Flow Statement API

Pull Cadrenal Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CVKD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY